Haemonetics
301 hedge funds and large institutions have $4.19B invested in Haemonetics in 2023 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 113 increasing their positions, 112 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 294 → 301 (+7)
1.08% more ownership
Funds ownership: 99.53% → 100.61% (+1.1%)
1% more repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 112
Holders
301
Holding in Top 10
3
Calls
$8.61M
Puts
$5.34M
Top Buyers
| 1 | +$57.7M | |
| 2 | +$52.2M | |
| 3 | +$20.9M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$18.1M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$12.7M |
Top Sellers
| 1 | -$37.7M | |
| 2 | -$34.5M | |
| 3 | -$28.5M | |
| 4 |
Neuberger Berman Group
New York
|
-$17.5M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
-$17.2M |